AlhopuroP., Ylisaukko-OjaS.K., KoskinenW.J., BonoP., ArolaJ., JärvinenH.J., MecklinJ.P., AtulaT., KontioR., MäkitieA.A., SuominenS., LeivoI., VahteristoP., AaltonenL.M., AaltonenL.A.2005. The MDM2 promoter polymorphism SNP309T—>G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck. J Med Genet, 42:694–698.
2.
BocciaS., De FeoE., GallìP., GianfagnaF., AmoreR., RicciardiG.2010. A systematic review evaluating the methodological aspects of meta-analyses of genetic association studies in cancer research. Eur J Epidemiol, 25:765–775.
3.
CaoX., ZhangT., ZhaoZ., ZhaoT.2011. MDM2 SNP309 polymorphism and colorectal cancer risk: a meta-analysis. DNA Cell Biol[Epub ahead of print]www.liebertonline.com/doi/abs/10.1089/dna.2011.1338
4.
KavvouraF.K., IoannidisJ.P.2008. Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet, 123:1–14.
5.
LiberatiA., AltmanD.G., TetzlaffJ., MulrowC., GøtzscheP.C., IoannidisJ.P., ClarkeM., DevereauxP.J., KleijnenJ., MoherD.2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol, 62:e1–e34.
6.
LittleJ., BradleyL., BrayM.S., ClyneM., DormanJ., EllsworthD.L., HansonJ., KhouryM., LauJ., O'BrienT.R., RothmanN., StroupD., TaioliE., ThomasD., VainioH., WacholderS., WeinbergC.2002. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol, 156:300–310.
7.
PanZ., TrikalinosT.A., KavvouraF.K., LauJ., IoannidisJ.P.2005. Local literature bias in genetic epidemiology: an empirical evaluation of the Chinese literature. PloS Med, 2:e334.
8.
SotamaaK., LiyanarachchiS., MecklinJ.P., JärvinenH., AaltonenL.A., PeltomäkiP., de la ChapelleA.2005. p53 codon 72 and MDM2 SNP309 polymorphisms and age of colorectal cancer onset in Lynch syndrome. Clin Cancer Res, 11:6840–6844.
9.
SuganoN., SudaT., GodaiT.I., TsuchidaK., ShiozawaM., SekiguchiH., YoshiharaM., MatsukumaS., SakumaY., TsuchiyaE., KamedaY., AkaikeM., MiyagiY.2010. MDM2 gene amplification in colorectal cancer is associated with disease progression at the primary site, but inversely correlated with distant metastasis. Genes. Chromosomes. Cancer, 49:620–629.
